(3,5-Difluoro-4-hydroxyphenyl)boronic acid, 95.0%, 5g

4-(3-Pyridin-3-yl-[1,2,4]oxadiazol-5-yl)-butyric acid, 95.0%, 1g

8-Bromo-5-(methylthio)-[1,2,4]triazolo[4,3-c]pyrimidine, 97%, 1g

Ethyl 2,5-dimethylpyrazolo[1,5-a]pyrimidine-7-carboxylate, 98%, 5g

6-Amino-3-chloropicoline, 95.0%, 25g

(1R,2R)-2-((R)-1-phenylethylamino)cyclohexanol, 98%, 100mg

2-Fluoro-5-methylphenylboronic acid, 97.00%, 5g

5-Ethyl-2-hydroxy-benzaldehyde, 95.0%, 5g

(2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-N-(2-(2-(4-formylphenoxy)ethoxy)-4-(4-methylthiazol-5-yl)benzyl)-4-hydroxypyrrolidine-2-carboxamide, 97%, 250mg

2-Bromo-1-(5-pyridin-2-yl-thiophen-2-yl)-ethanone, 95.0%, 5g

Cobalt(II,III) oxide, min. 71% Co, pa, 500 g, plastic packaging.

3-Amino-3-(2,3-dichlorophenyl)propanoic acid, 98%, 250mg

Methyl 2-Benzoylbenzoate>98.0%(GC)500g